Skip to main
LQDA

LQDA Stock Forecast & Price Target

LQDA Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 67%
Buy 22%
Hold 0%
Sell 11%
Strong Sell 0%

Bulls say

Liquidia Corp has demonstrated a positive trajectory in its financial outlook, particularly with the strong launch ramp of YUTREPIA, reflected in the revised peak sales estimates increasing from $1.2 billion to a range of $1.7 billion to $2 billion. The operating profitability achieved in the first full quarter of YUTREPIA's launch indicates strong market acceptance, supported by an improved conversion rate of 85% for patients being switched to YUTREPIA. Furthermore, strategic financial agreements with major payors and the favorable competitive positioning of its novel delivery device enhance potential market penetration and revenue growth opportunities.

Bears say

Liquidia Corp faces considerable legal risks that could threaten the exclusivity of its primary revenue source from YUTREPIA, which is a significant contributor to its top-line growth. Should the company not prevail in ongoing legal challenges related to patent assertions and trade secret misappropriation, it may face substantial financial penalties and disruptions in sales. Furthermore, the uncertainty surrounding YUTREPIA's freedom to operate could explain the current large discount to Liquidia's growth potential, reflecting broader concerns about the sustainability of its revenue stream amidst these legal challenges.

LQDA has been analyzed by 9 analysts, with a consensus rating of Buy. 67% of analysts recommend a Strong Buy, 22% recommend Buy, 0% suggest Holding, 11% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Liquidia Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Liquidia Technologies Inc (LQDA) Forecast

Analysts have given LQDA a Buy based on their latest research and market trends.

According to 9 analysts, LQDA has a Buy consensus rating as of Dec 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $37.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $37.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Liquidia Technologies Inc (LQDA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.